JP2010523141A5 - - Google Patents

Download PDF

Info

Publication number
JP2010523141A5
JP2010523141A5 JP2010502629A JP2010502629A JP2010523141A5 JP 2010523141 A5 JP2010523141 A5 JP 2010523141A5 JP 2010502629 A JP2010502629 A JP 2010502629A JP 2010502629 A JP2010502629 A JP 2010502629A JP 2010523141 A5 JP2010523141 A5 JP 2010523141A5
Authority
JP
Japan
Prior art keywords
mel
dsmz
deposited
culture collection
number dsm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010502629A
Other languages
English (en)
Japanese (ja)
Other versions
JP5762738B2 (ja
JP2010523141A (ja
Filing date
Publication date
Priority claimed from ARP070101520A external-priority patent/AR060424A1/es
Application filed filed Critical
Publication of JP2010523141A publication Critical patent/JP2010523141A/ja
Publication of JP2010523141A5 publication Critical patent/JP2010523141A5/ja
Application granted granted Critical
Publication of JP5762738B2 publication Critical patent/JP5762738B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010502629A 2007-04-11 2008-04-11 細胞株、黒色腫の治療のためにそれを含む組成物、組成物の製造手順および治療方法 Active JP5762738B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ARP20070101520 2007-04-11
ARP070101520A AR060424A1 (es) 2007-04-11 2007-04-11 Lineas celulares , composiciones para el tratamiento de melanomas que las comprenden procedimientos para preparar las composiciones y metodos de tratamiento
PCT/IB2008/051385 WO2008126039A2 (en) 2007-04-11 2008-04-11 Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods

Publications (3)

Publication Number Publication Date
JP2010523141A JP2010523141A (ja) 2010-07-15
JP2010523141A5 true JP2010523141A5 (cg-RX-API-DMAC7.html) 2011-05-26
JP5762738B2 JP5762738B2 (ja) 2015-08-12

Family

ID=39590605

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010502629A Active JP5762738B2 (ja) 2007-04-11 2008-04-11 細胞株、黒色腫の治療のためにそれを含む組成物、組成物の製造手順および治療方法

Country Status (17)

Country Link
US (1) US8501168B2 (cg-RX-API-DMAC7.html)
EP (1) EP2146742B1 (cg-RX-API-DMAC7.html)
JP (1) JP5762738B2 (cg-RX-API-DMAC7.html)
KR (1) KR101502518B1 (cg-RX-API-DMAC7.html)
CN (1) CN101861163B (cg-RX-API-DMAC7.html)
AR (1) AR060424A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008238909B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0809767B1 (cg-RX-API-DMAC7.html)
CA (1) CA2683629C (cg-RX-API-DMAC7.html)
CO (1) CO6260100A2 (cg-RX-API-DMAC7.html)
DK (1) DK2146742T3 (cg-RX-API-DMAC7.html)
ES (1) ES2390130T3 (cg-RX-API-DMAC7.html)
MX (1) MX2009010927A (cg-RX-API-DMAC7.html)
NZ (1) NZ580533A (cg-RX-API-DMAC7.html)
RU (1) RU2484134C2 (cg-RX-API-DMAC7.html)
WO (1) WO2008126039A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200907240B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6077735B2 (ja) * 2011-06-08 2017-02-08 日本電子株式会社 電子顕微鏡観察用染色剤および電子顕微鏡観察用試料の染色方法
SG11201401631VA (en) 2011-10-20 2014-05-29 California Stem Cell Inc Antigen presenting cancer vaccine with gamma interferon
JP6077757B2 (ja) * 2012-04-17 2017-02-08 日本電子株式会社 電子顕微鏡観察用染色剤および電子顕微鏡観察用試料の染色方法
JP5921386B2 (ja) * 2012-08-27 2016-05-24 日本電子株式会社 電子顕微鏡観察用染色剤および電子顕微鏡観察用試料の染色方法
CN103146641B (zh) * 2013-02-06 2015-03-25 云南中科灵长类生物医学重点实验室 多能干细胞的传代方法及其用途
CN104990781B (zh) * 2015-06-29 2018-02-16 中国医学科学院皮肤病研究所 黑素细胞免疫组化苏木素—甲苯胺蓝双重复染法
AU2020395765A1 (en) 2019-12-03 2022-06-16 Neuvogen, Inc. Tumor cell vaccines
RU2755233C1 (ru) * 2021-01-11 2021-09-14 Сергей Анатольевич Яргунин Способ лечения меланомы кожи IIb-IIc стадий
CN115074328B (zh) * 2022-06-21 2025-02-07 中国人民解放军空军军医大学 一种用于治疗黑素瘤的细胞株及其多效价全细胞疫苗与使用方法
WO2025224605A1 (en) 2024-04-23 2025-10-30 Consejo Nacional De Investigaciones Científicas Y Técnicas (Conicet) Sequential administration of anti-melanoma vaccine and anti-pd-1 monoclonal antibodies

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882654A (en) * 1989-11-03 1999-03-16 Morton; Donald L. Polyvalent melanoma vaccine
KR20000022445A (ko) * 1996-07-10 2000-04-25 크리스토퍼 엘. 와이트, 스코트 지. 홀퀴스트, 스티븐 엘. 말라스카 수상돌기 세포의 활성화 방법
AU3889997A (en) * 1996-08-16 1998-03-06 Johns Hopkins University School Of Medicine, The Melanoma cell lines expressing shared immunodominant melanoma antigens nd methods of using same
WO1999042564A2 (en) * 1998-02-20 1999-08-26 The Rockefeller University Apoptotic cell-mediated antigen presentation to dendritic cells
US7988963B1 (en) * 1999-10-15 2011-08-02 Baylor Research Institute Use of allogeneic cell lines to load antigen presenting cells to elicit or eliminate immune responses
WO2001028583A2 (en) * 1999-10-18 2001-04-26 St. Vincent's Hospital And Medical Center Of New York Melanoma vaccine and methods of making and using same
US7015205B1 (en) * 1999-10-18 2006-03-21 St. Vincent's Hospital And Medical Center Of New York Melanoma vaccine and methods of making and using same
WO2001048154A1 (en) * 1999-12-28 2001-07-05 Toyoshima, Kumao Maturation-promoting agent for immature dendritic cells
EP1326961B1 (en) * 2000-09-15 2007-08-22 Ortho-McNeil Pharmaceutical, Inc. Compositions and methods for inducing specific cytolytic t cell responses
US20030072737A1 (en) * 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
IL140796A0 (en) * 2001-01-08 2002-02-10 Hadasit Med Res Service An autologous anti-cancer vaccine
CA2440229A1 (en) * 2001-03-09 2002-09-19 Baylor Research Institute Method of treating malignancies through induction of blood immune responses
US7354909B2 (en) * 2001-08-14 2008-04-08 The United States Of America As Represented By Secretary Of The Department Of Health And Human Services Method for rapid generation of mature dendritic cells
EP1451305A4 (en) * 2001-11-07 2005-10-05 Mannkind Corp EPITOPE SYNCHRONIZATION IN CELLS THAT HAVE ANTIGENS
CN102600461B (zh) * 2002-12-06 2017-07-14 西北生物治疗药物公司 给予体外部分成熟的树突细胞治疗肿瘤
EP1623011B1 (en) * 2003-05-09 2013-01-02 Janssen Biotech, Inc. Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
JP5021309B2 (ja) * 2003-10-16 2012-09-05 ステファン ジョン ラルフ 免疫調節性組成物およびその使用方法
RU2262941C2 (ru) 2004-01-05 2005-10-27 Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН Способ иммунотерапии злокачественных опухолей головного мозга
EP1740946B1 (en) * 2004-04-20 2013-11-06 Genmab A/S Human monoclonal antibodies against cd20
CA2565874C (en) * 2004-05-10 2017-10-03 Macrogenics, Inc. Humanized fc.gamma.riib-specific antibodies and methods of use thereof
RU2283129C1 (ru) 2004-12-24 2006-09-10 Сергей Викторович Луценко Белковопептидный противоопухолевый композит, клеточный препарат, активированный этим композитом, и способ профилактики или лечения опухолей

Similar Documents

Publication Publication Date Title
RU2009141593A (ru) Клеточные линии, содержащие их композиции для лечения меланом, способы получения композиций и способы лечения
KR101077912B1 (ko) 제대혈로부터 효율적인 자연살해세포의 증식 및 분화 방법
KR101643165B1 (ko) 말초혈액단핵구 유래 자연 살해세포의 유도 및 증식 방법
Lu et al. Th9 cells promote antitumor immune responses in vivo
CN102292435B (zh) 牙齿相关干细胞的新用途
Gervais et al. Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency
CN113957051B (zh) 一种cik细胞培养基及培养方法
CN102321577A (zh) 抗肿瘤过继免疫细胞制备方法及制得的免疫细胞
CN105802908A (zh) 一种体外制备肿瘤抗原特异性cd8+干细胞样记忆性t淋巴细胞的方法
KR101447546B1 (ko) 제대혈 ｃｄ14 양성 단핵세포로부터 자연살해세포 분화 및 증식 방법
Shimabukuro-Vornhagen et al. The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect
Shekar et al. Phenotypic and growth characterization of human mesenchymal stem cells cultured from permanent and deciduous teeth
IL258071A (en) Methods related to activated branch cell preparations and immunotherapeutic therapies for patients with advanced cancer
KR101145391B1 (ko) 말초혈액으로부터 자연 살해세포의 증식 방법
Gel’m et al. Functional activity of lymphocytes of healthy donors and cancer patients after culturing with IL-2 and IL-15
Su et al. Coculturing dendritic cells with zoledronate acid efficiently enhance the anti-tumor effects of cytokine-induced killer cells
Wang et al. Effect of dendritic cell vaccine against a tongue squamous cell cancer cell line (Tca8113) in vivo and in vitro
CN103509753A (zh) 一种人体造血干细胞分化培养方法
KR20190091020A (ko) 진세노사이드 Rg3를 유효성분으로 포함하는 차세대 수지상세포로의 성숙화 유도용 조성물 및 이를 이용한 차세대 수지상세포 제조방법
Isaikina et al. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro
CN105219714A (zh) 一种用于激活肺癌特异性免疫反应的试剂盒
Aversa et al. Fourth international workshop on haploidentical transplants, Naples, Italy, July 8–10, 2004
Tiao et al. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness
CN105219723A (zh) 一种用于激活胃癌特异性免疫反应的试剂盒
Ageitos et al. IL-2 expansion of T and NK cells from growth factor-mobilized peripheral blood stem cell products: monocyte inhibition